9 research outputs found
Three Futures for Postcrisis Banking in the Americas: The Financial Trilemma and the Wall Street Complex
Minimal information for studies of extracellular vesicles 2018 (MISEV2018):a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points
Social Movements and the Politics of Debt Cancellation
The question of sovereign debt restructuring has come up in the last three years, primarily in response to the plight of Argentina, which in 2001 was forced into the largest governmental default in recent decades. The Sovereign Debt Restructuring Mechanism ( SDRM ) proposed by the International Monetary Fund ( IMF ) in 2002, while failing to win approval from the institution\u27s board, was a very narrow response to a narrowly defined aspect of the global debt crisis. This article discusses the SDRM, but is more concerned with the larger scope of advocacy on debt issues by civil society movements over the last two decades. While it does take up legal strategies being used in those efforts, it is concerned with such tactics only in the context of the urgent calls for the elimination of the destructive cycle of debt afflicting most of the countries of the Global South. Its primary concern is to make the case that governments are obligated first and foremost to protect the interests of their citizens, and therefore should use the necessary political capital at their disposal to repudiate debt payments that handcuff their capacity to improve people\u27s lives and inhibit democratic self-determination of countries\u27 most salient policy decisions
Social Movements and the Politics of Debt Cancellation
The question of sovereign debt restructuring has come up in the last three years, primarily in response to the plight of Argentina, which in 2001 was forced into the largest governmental default in recent decades. The Sovereign Debt Restructuring Mechanism ( SDRM ) proposed by the International Monetary Fund ( IMF ) in 2002, while failing to win approval from the institution\u27s board, was a very narrow response to a narrowly defined aspect of the global debt crisis. This article discusses the SDRM, but is more concerned with the larger scope of advocacy on debt issues by civil society movements over the last two decades. While it does take up legal strategies being used in those efforts, it is concerned with such tactics only in the context of the urgent calls for the elimination of the destructive cycle of debt afflicting most of the countries of the Global South. Its primary concern is to make the case that governments are obligated first and foremost to protect the interests of their citizens, and therefore should use the necessary political capital at their disposal to repudiate debt payments that handcuff their capacity to improve people\u27s lives and inhibit democratic self-determination of countries\u27 most salient policy decisions
Corrected Super-Resolution Microscopy Enables Nanoscale Imaging of Autofluorescent Lung Macrophages
Observing the cell surface and underlying cytoskeleton at nanoscale resolution using super-resolution microscopy has enabled many insights into cell signaling and function. However, the nanoscale dynamics of tissue-specific immune cells have been relatively little studied. Tissue macrophages, for example, are highly autofluorescent, severely limiting the utility of light microscopy. Here, we report a correction technique to remove autofluorescent noise from stochastic optical reconstruction microscopy (STORM) data sets. Simulations and analysis of experimental data identified a moving median filter as an accurate and robust correction technique, which is widely applicable across challenging biological samples. Here, we used this method to visualize lung macrophages activated through Fc receptors by antibody-coated glass slides. Accurate, nanoscale quantification of macrophage morphology revealed that activation induced the formation of cellular protrusions tipped with MHC class I protein. These data are consistent with a role for lung macrophage protrusions in antigen presentation. Moreover, the tetraspanin protein CD81, known to mark extracellular vesicles, appeared in ring-shaped structures (mean diameter 93 ± 50 nm) at the surface of activated lung macrophages. Thus, a moving median filter correction technique allowed us to quantitatively analyze extracellular secretions and membrane structure in tissue-derived immune cells
Thigh-length compression stockings and DVT after stroke
Controversy exists as to whether neoadjuvant chemotherapy improves survival in patients with invasive bladder cancer, despite randomised controlled trials of more than 3000 patients. We undertook a systematic review and meta-analysis to assess the effect of such treatment on survival in patients with this disease
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19. Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospital with COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients were randomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once per day by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatment groups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment and were twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants and local study staff were not masked to the allocated treatment, but all others involved in the trial were masked to the outcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) were eligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was 65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomly allocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall, 561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days (rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median 10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days (rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, no significant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilation or death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24). Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or other prespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restricted to patients in whom there is a clear antimicrobial indication. Funding UK Research and Innovation (Medical Research Council) and National Institute of Health Research
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The last decade has seen a sharp increase in the number
of scientific publications describing physiological and
pathological functions of extracellular vesicles (EVs), a
collective term covering various subtypes of cell-released,
membranous structures, called exosomes, microvesicles,
microparticles, ectosomes, oncosomes, apoptotic bodies, and many
other names. However, specific issues arise when working with
these entities, whose size and amount often make them difficult
to obtain as relatively pure preparations, and to characterize
properly. The International Society for Extracellular Vesicles
(ISEV) proposed Minimal Information for Studies of Extracellular
Vesicles ("MISEV") guidelines for the field in 2014. We now
update these "MISEV2014" guidelines based on evolution of the
collective knowledge in the last four years. An important point
to consider is that ascribing a specific function to EVs in
general, or to subtypes of EVs, requires reporting of specific
information beyond mere description of function in a crude,
potentially contaminated, and heterogeneous preparation. For
example, claims that exosomes are endowed with exquisite and
specific activities remain difficult to support experimentally,
given our still limited knowledge of their specific molecular
machineries of biogenesis and release, as compared with other
biophysically similar EVs. The MISEV2018 guidelines include
tables and outlines of suggested protocols and steps to follow
to document specific EV-associated functional activities.
Finally, a checklist is provided with summaries of key points